Delirium, Anxiety And Terminal Agitation

2y ago
36 Views
2 Downloads
1.07 MB
44 Pages
Last View : 8d ago
Last Download : 3m ago
Upload by : Kairi Hasson
Transcription

Delirium, Anxiety andTerminal AgitationDr Graham WhyteConsultant in Palliative MedicineMarie Curie Hospice GlasgowNov 2016

2Case History 1– W.W. 57 yr old male, Lung adenocarcinoma with widespread bone metastases andpathological fracture right femur Phx – Alcohol Excess and polysubstance misuse/dependence Lives alone, socially isolated, house barley habitable, many years in prison (forviolent offences) Issues with uncontrolled pain, constipation and decreasing mobility Initially no cognitive impairment, AMT 4/4 although obnoxious and irritable Behavioural change over 1 week with increasing agitation, hostility, episodesof paranoia Fluctuating lucidity, unable to rationalise decisions, alteredsleep/wake cycleWhat are your thoughts?How would you manage this situation?Could this be managed at home?

3MedicationOxycodone 200mg/24hours via csciParacetamol 1g qdsMidazolam 5mg/ 24 hours via csciSeretide and Tiotropium InhalersThiamine 100mg tdsDiclofenac 150mg/24 hours via csciParoxetine 30mg odDexamethasone 8mg dailyOxynorm 50mg PRN 4-5 times dailyOmeprazole 40mgNicotine PatchNitrazepam 10mg nocte

4Differential DiagnosisAnti-social personality disorderAlcohol related brain injuryHypercalcaemia? Brain Metastases? Terminal Agitation

Delirium Latin term meaning “going offthe ploughed track."

6Delirium - What do we know? Common Under recognised and under treated Bad outcome – 25% mortality and high morbidity Preventable and treatable But can persists for weeks or months after cause treated

IncidenceGeneral Medicine In patientOld Age Medicine In patientIntensive CareIn patients with dementiaIn patients with palliative care needsNursing HomeInouye S.K. et al (2014) Delirium in Elderly People, Lancet11-14%20-29%19-82%56%47%20-22%

8Risk factors for delirium? Acute Illness Age 70 years Sensory Impairment Recent Surgery Recent Discharge from hospital DementiaUse of Opioids, benzodiazepines,anti-cholinergics Polypharmacy Frailty Depression Catheterised Patients approaching end of life Acute or Chronic Pain

Diagnosis v’s eDisturbance ofConsciousnessDeliriumSyndromeICD 10SuddenOnsetFluctuationsDisturbance ofCognition

Delirium v’s DementiaFeatureDeliriumDementiaMode of onsetAcute/ subacuteChronicPoor attentionCharacteristicLate featureConscious LevelOften affected ,fluctuates NormalHallucinationsCommonLate featureFear, agitation,aggressionCommonNot common in earlystagesSpeechSlurredNormalMotor signsPostural Tremor,myoclonus, asterixisNone, or late feature

Subtypes: Hypoactive- slowedmotor function, lethargy, decreasedawareness and interaction, misdiagnosed as depression Hyperactive – increased arousal agitation Mixed - features of both, fluctuates (worse at night, lucidintervals during the day)

12Assessment if clinical suspicionSQID Single Question to Identify Delirium“Do you think (name of patient) has been more confusedlately”?

13Identifying Delirium

15Abbreviated Mental Test (AMT 4) – assess baselinecognition Age Date of Birth Place Year Little loss of accuracy in detecting marked cognitive impairment whencompared to the AMT 10

Causes:rugs (new or withdrawal)thanole ectrolytesnfectionespiratory (02/CO2)ntracranial (bleed / infarct / tumour)rinary retention (and Constipation)yocardial Infarctionugar

17Assessment of Delirium Medication Review – changes, concordance, rationalise Investigations – as appropriate with aims of care Optimise Management of Co-morbidity Often multiple causes but in up to 30% no cause found ‘Time Bundle’ – being used in GRI

18Multi-component intervention to manage andprevent delirium Medical and Nursing Management – pain assessment, prevent hypoxia, treatconstipation etc, person centred care e.g. “Getting to know me document” Environmental and General Measures – orientation, mobilisation, sleephygiene, avoid inappropriate interventions Assessment of Capacity – is AWI section 47 needed for basic care? Treatment of Delirium Symptoms

20Treatment of Delirium Symptoms Only consider medication if essential to control symptoms First Choice : Haloperidol 0.5-1mg orallyHaloperidol 0.5mg S/C/IM Avoid if signs of Parkinsonism or Lewy Body Dementia Second Choice: Lorazepam 0.5- 1mg orallyMidazolam 2-5mg s/c Benzodiazepines do not improve cognition but may help anxiety, use withcaution. Higher doses may be required Other antipsychotics may be considered - Risperidone, Olanzapine,Quetiapine

Dementia and DeliriumWhat we do know:1. Delirium often does not fully resolve2. After delirium dementia is morecommonTheories1. Delirium as a marker2. Delirium as a trigger3. Delirium as a cause4. Treatment of Delirium as a cause3. People with dementia get deliriummore 69% of patients with delirium will have dementia with 5 years(MacLullich AM et al (2009) Delirium and Long Term Cognitive Impairment, International Review of Psychiatry)

22Follow Up - Whose job is delirium? High risk of further episodes of delirium Can persist for weeks or months after cause treated Progression to Dementia

23Managing Anxiety in Palliative Patients

Case History 2 – W.P. 72yr old lady Pleural Mesothelioma initially diagnosed Jan 2014 Worked for MOD before retiring, contracted mesothelioma when ClericalWorker in factory that made asbestos panels Always been a very fit and active person – walking groups etc. Lives alone,widowed, very supportive daughter. Initial MDT decision ‘watchful waiting’ Dec 2014 Progressive chest wall disease Jan 2015 Completed Palliative Radiotherapy March 2015 Acute Hospital Admissions – Septic shock, AKI, HDU briefly –responded well to treatment and discharged Since discharge – anxiety a major issue, on wakening in the morning veryanxious and episodes during the day when become very emotional anddistressed What are your thoughts? How would you manage this situation?

25Medications Bendroflumathiazide 2.5mg Paracetamol 1g qds Carbocisteine 750mg tds Salbutamol 2 puffs prn Latanoprost Symbicort 2 Puffs bd Laxido 1 sachet daily Zopiclone 3.75mg nocte MST 20mg bd Oramorph 10mg prn

26Anxiety in Advanced Illness Not inevitable Acute or Chronic Prevalence increases with advancing disease Often presents as complex mix of physical and psychologicalsymptoms

27Symptoms of AnxietyPsychologicalApprehensionCannot distract ritabilityIntrusive thoughts of deathTense, unable to relaxPoor ConcentrationMay be associated depressive illnessPhysicalCNS – headache, tremor, fatigue,dizziness, paraesthesia ,panic attacksGI - nausea, dry mouth, indigestion,diarrhoeaCVS – Palpitations, chest painRESP – HyperventilationGU – Urinary frequency, impotenceSKIN – rash, sweating

28Notes: further details here (or delete)Source: details here (or delete)

29Complex relationship with other symptomsPhysical:Pain, other symptoms general declineSocial:Relationships with family, role in family,work role, financial concernsAnxietyPsychological:Grief, depression, anger, adjustment,future fears, regretsNotes: further details here (or delete)Spiritual:Existential Issues, Religious faith,Meaning of Life and Illness, PersonalValues

30Causes of anxietyUncontrolled SymptomsPhysical DisordersDrugs Insomnia Brain tumour Corticosteroids Breathlessness Cardiac Arrhythmias Benzodiazepines Nausea Hyperthyroidism Opioids Severe Pain Hypoglycaemia Br

Dementia and Delirium What we do know: 1. Delirium often does not fully resolve 2. After delirium dementia is more common 3. People with dementia get delirium more Theories 1. Delirium as a marker 2. Delirium as a trigger 3. Delirium as a cause 4. Treatment of Delirium as a cause 69% of patients with

Related Documents:

If delirium is suspected, treat for delirium until confirmation by the medical team. 1.5.2 Ensure that the diagnosis of delirium is documented in the patient's clinical record. 1.5.3 Commence a delirium care plan 1.5.4 Note on the hourly care rounds any signs of delirium in order to document the fluctuations. 1.6 Treating delirium Initial .

Delirium risk can be anticipated using available tools All ICUs should use a validated tool to diagnose delirium systematically Distinguishing agitation from non-agitated delirium is important in terms of therapeutic approach A systematic approach to diagnosing the cause of agitation is vital

delirium. If it has not been possible to establish whether a person has delirium, dementia or delirium superimposed on dementia, the referrer should treat for delirium first. For guidance on treating delirium, see NICE guidance Delirium: prevention, diagnosis and management 2010, updated 2019 (CG103)3. The referrer should also screen for other .

Management of Delirium, Agitation and Sympathetic µStorming ¶ Management of Delirium, Agitation and Sympathetic µStorming ¶ AGITATION GCS 8 Disturbed behaviour seen as an early symptom in patients with post-traumatic amnesia (PTA) Resolves with return of ability to retrieve and store information In longer term usually due to personality .

3 Clinical transformation and education: Consultancy and training to educate staff so they can effectively implement delirium management improvements 2 Delirium management analysis: Assesses the delirium-related factors that need to be addressed to improve delirium management based on measured data 4 Interventions and improvements:

absence) of delirium. This data was then extracted into a large data set and cleaned. The risk factors were used to create a delirium prediction model which was incorporated into the EMR to run in real time. Results: The data set includes data from 13,819 unique patients and 153,212 independent delirium screens. Delirium incidence is 29.6%.

Table 2. Wiring terminal references for non-Excel 10/12 devices signal T7460A terminal T7460B terminal T7460C terminal Excel 800 XF82x terminal (example) Excel 500 XF52xB terminal (example) Excel 500 XFL52x terminal (example) Excel 100 terminal (example) Excel 50 terminal (example) Excel 20 terminal (example) CPO-FB22344R terminal (example)

The American Board of Radiology . i The Diagnostic Radiology Milestone Project The Milestones are designed only for use in evaluation of resident physicians in the context of their participation in ACGME accredited residency or fellowship programs. The Milestones provide a framework for the assessment of the development of the resident physician in key dimensions of the elements of physician .